Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
07/2007
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity
07/05/2007US20070155970 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives
07/05/2007US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS
07/05/2007US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
07/05/2007US20070155756 Treatment of chemokine mediated diseases
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/04/2007EP1565450B1 Tetrahydropyran derivatives
07/04/2007CN1990478A 6-aryl-3-substituted methylene pyranone compounds, preparation process and use thereof
07/04/2007CN1990452A Process to produce a protease inhibitor
06/2007
06/28/2007WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/28/2007US20070149615 Ketone compounds and compositions for cholesterol management and related uses
06/28/2007US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives
06/28/2007CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
06/27/2007EP1799645A2 Processes and intermediates for preparing cysteine protease inhibitors
06/27/2007CN1989100A Therapeutic compounds
06/27/2007CN1323078C Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same
06/21/2007WO2007018954A3 Application of a bioactive agent in a solvent composition to produce a target particle morphology
06/21/2007WO2007018887A3 Application of a bioactive agent to a substrate
06/21/2007US20070142347 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142230 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
06/20/2007EP1798228A1 Tetrahydropyran compounds, liquid crystal compositions, and liquid crystal displays containing the compositions
06/20/2007EP1798214A1 Process for recovering statin compounds from a fermentation broth
06/20/2007EP1797098A2 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
06/20/2007CN1984898A Process for production of azulene derivatives and intermediates for the synthesis of the same
06/20/2007CN1982296A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/20/2007CN1322001C Novel compounds that inhibit factor Xa activity
06/14/2007US20070135517 Antitumor medicine
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/14/2007US20070135475 Process for the preparation of ccr-2 antagonists
06/14/2007US20070135332 Fragrance composition
06/14/2007US20070134594 Fluorescent dye and structure and manufacturing method of fluorescent storage media using thereof
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007CN1980936A 2,4,6-phenylsubstituted cyclic ketoenoles.
06/12/2007US7230114 Intermediates for preparing neuraminidase inhibitor conjugates
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230028 Dimeric compounds and their use as anti-viral agents
06/12/2007US7229576 Photochromic compounds derived from 2H-phenanthro[2,1-b]pyrans and 3H-phenanthro[3,4-b]pyrans, which in the open form have especially long wavelength absorption maxima, but in the unexcited state are still colorless, to their use in synthetic resin materials of all types, for ophthalmic purposes
06/12/2007CA2354023C Phenylglycine derivatives
06/07/2007WO2007063928A1 Novel noncyclic amine carboxamide derivative and salt thereof
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007US20070129252 2-Halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/06/2007EP1451147A4 Amino acid derivatives
06/06/2007CN1976911A Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
06/06/2007CN1319929C Aryl phenyl substituted cyclic ketoenols
06/05/2007US7226918 DNA-PK inhibitors
05/2007
05/31/2007WO2007060408A2 L-phenylalanine derivatives and their use as integrin antagonists
05/30/2007EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
05/30/2007CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
05/30/2007CN1970558A lactic acid base puerarin derivative preparation method
05/30/2007CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
05/29/2007US7223790 Dimeric compounds and their use as anti-viral agents
05/24/2007US20070117991 reaction with thionyl chloride to form 5-chlorocarbonyl phthalide intermediate which is reacted with hydroxylamine and then dehydrated; one pot process; intermediate is not isolated; no dangerous reagents; product is intermediate for Citalopram
05/24/2007US20070117848 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis
05/23/2007EP1787657A1 Therapeutic agent for psychoneurotic disease
05/23/2007EP1523542B1 Fragrance composition
05/22/2007US7220783 Para-terphenyl compounds
05/22/2007CA2212200C Novel inhibitors of .beta.-glucuronidase
05/18/2007WO2007054254A1 Organic compounds
05/18/2007WO2007017695A3 Dihydroxyanthraquinones and their use
05/18/2007WO2006122020A3 Process for production of 4-biphenylyazetidin-2-ones
05/18/2007CA2626705A1 Organic compounds
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111952 Glycosylated triketide delta lactones
05/17/2007US20070108410 nematic phase consisting of a lactone ring of pyranone, a cyclohexylene or 1,4-phenylene ring, or replaced by one or more fluorine; controlling temperature, optical and dielectric anisotropy, photostability, heat resistance
05/16/2007CN1964718A Leptomycin compounds
05/16/2007CN1962653A Method for synthesis of delta-undeca lactone
05/16/2007CN1962596A Ketone compounds and compositions for cholesterol management and related uses
05/16/2007CN1316032C Chemical-enzymatic synthesis process for optical-enriched rose oxide
05/10/2007WO2007051846A1 Tricyclo substituted amides
05/10/2007WO2007025943A3 Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
05/10/2007WO2006016178A8 Enantioselective process
05/10/2007US20070106083 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same
05/10/2007CA2628486A1 Tricyclo substituted amides
05/09/2007EP1783122A1 Process for production of azulene derivatives and intermediates for the synthesis of the same
05/09/2007EP1781662A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
05/09/2007CN1314641C Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
05/08/2007US7214708 potent inhibitor of tumor cell growth, acting via a microtubule stabilization mechanism; for treating a hyperproliferative disease
05/08/2007US7214707 Dimeric compounds and their use as anti-viral agents
05/08/2007US7214681 Tri(cyclo) substituted amide compounds
05/08/2007CA2182878C Novel cytotoxic macrolides and methods of use
05/03/2007WO2007021858A3 Methods of making radiolabeled tracers and precursors thereof
05/03/2007US20070099826 Treatment of diseases associated with the egr-1 enhancer element
05/02/2007EP1778678A1 Enantioselective process
05/02/2007EP1594835A4 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
04/2007
04/26/2007WO2007045382A1 Spiro [3.3] heptyl-dioxan derivatives and their use in liquid crystal media
04/26/2007WO2007031548A3 Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
04/26/2007US20070093660 Method for the production of statins
04/25/2007CN1953963A Process for producing cyclic N-hydroxyimide compound
04/24/2007US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
04/24/2007US7208497 Substituted piperazines and diazepanes
04/19/2007WO2007011629A3 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use
04/19/2007WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof
04/18/2007EP1773800A1 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof
04/18/2007EP1773780A2 Amido compounds and their use as pharmaceuticals
04/18/2007EP1773284A1 Beta-substituted tetrahydropyran(on)s and method for the synthesis and the use thereof
04/18/2007EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 129